| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_872d30b3e694f197b1d77caf32578b9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3068fd17d1bff91d9a6555987bd4b60d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-345
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-345 |
| filingDate |
2003-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cf52c9b23d98274b90b2c10eb4237f9 |
| publicationDate |
2004-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004089340-A1 |
| titleOfInvention |
Pharmaceutical compositions, method, and use of formulation for the treatment and prevention of infections associated with helicobacter pylori in mammals and humans |
| abstract |
The present invention relates to pharmaceutical compositions, which associate antibiotics with proton pump inhibitors and their applications in the treatment and prevention of infections caused by Helicobacter pylori. More precisely, the present invention relates to oral pharmaceutical compositions containing three active drugs against H. pylori infections, where at least an antibiotic belongs to nitrofuran class and is associated to at least a second antibiotic that can be of macrolide or tetracycline class and are associated to an proton pump inhibitor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3034077-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9511080-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008114143-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011079349-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1905426-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1905426-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013172298-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8093271-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7968118-B2 |
| priorityDate |
2003-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |